Profile
Doros Platika is currently the President & Chief Executive Officer at the Supercentenarian Research Foundation and a Director at WorldCare, Inc. He previously served as President & Chief Executive Officer at Curis, Inc., Ontogeny, Inc., Centagenetix, Inc., and Pittsburgh Life Sciences Green House.
He was also a Director at V.I.
Technologies, Inc. and Cohera Medical, Inc. In addition, he held the position of Executive Vice President-Research & Development at Progenitor, Inc. Dr. Platika received his undergraduate degree from The Reed Institute and his doctorate from Stony Brook University.
Doros Platika active positions
| Companies | Position | Start |
|---|---|---|
Supercentenarian Research Foundation | Chief Executive Officer | - |
WorldCare, Inc. (Massachusetts)
WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services Develops and commercializes global healthcare services and solutions | Director/Board Member | - |
Former positions of Doros Platika
| Companies | Position | End |
|---|---|---|
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Director/Board Member | 10/03/2005 |
| CURIS, INC. | Chief Executive Officer | 31/08/2001 |
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | Chief Tech/Sci/R&D Officer | - |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | President | - |
Centagenetix, Inc.
Centagenetix, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics to slow the aging process | President | - |
Training of Doros Platika
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | Health Technology |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Health Technology |
Curis, Inc.
Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Cohera Medical, Inc.
Cohera Medical, Inc. Medical SpecialtiesHealth Technology Develops surgical adhesives and sealants | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Health Technology |
Centagenetix, Inc.
Centagenetix, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics to slow the aging process | Commercial Services |
The Reed Institute
The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stony Brook University
Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WorldCare, Inc. (Massachusetts)
WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services Develops and commercializes global healthcare services and solutions | Health Services |
Pittsburgh Life Sciences Green House
Pittsburgh Life Sciences Green House Investment ManagersFinance PLSG invests in companies located in the United States, primarily in Western Pennsylvania. The firm focuses on the life sciences sector. It provides financing for seed, early and growth stage capital requirements. | Finance |
Supercentenarian Research Foundation |
- Stock Market
- Insiders
- Doros Platika
















